These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29352840)

  • 1. Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.
    Ahn SS; Hong SH; Park Y; Jung SM; Song JJ; Park YB; Lee SW; Park SG
    Clin Exp Rheumatol; 2018; 36(4):533-539. PubMed ID: 29352840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
    Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
    Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
    Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
    Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.
    Ahn SS; Park Y; Lee DD; Bothwell ALM; Jung SM; Song JJ; Park YB; Lee SW
    Lupus; 2018 Apr; 27(5):771-779. PubMed ID: 29233037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of cytokine models in predicting SLE activity.
    Ruchakorn N; Ngamjanyaporn P; Suangtamai T; Kafaksom T; Polpanumas C; Petpisit V; Pisitkun T; Pisitkun P
    Arthritis Res Ther; 2019 Dec; 21(1):287. PubMed ID: 31842967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus.
    Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Lupus; 2018 Sep; 27(10):1697-1705. PubMed ID: 30020022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
    Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
    Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T
    Front Immunol; 2018; 9():1250. PubMed ID: 29930551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
    Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
    Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin to globulin ratio (AGR) in systemic lupus erythematosus: correlation with disease activity.
    Liu M; Li X; Huang Y; Huang Z; Huang Q
    J Int Med Res; 2024 Apr; 52(4):3000605241244761. PubMed ID: 38661083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phosphatidylserine-specific phospholipase A
    Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
    Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
    Matsuoka N; Fujita Y; Temmoku J; Furuya MY; Asano T; Sato S; Matsumoto H; Kobayashi H; Watanabe H; Suzuki E; Kozuru H; Yastuhashi H; Migita K
    PLoS One; 2020; 15(1):e0227069. PubMed ID: 31986153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
    Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?
    Amital H; Szekanecz Z; Szücs G; Dankó K; Nagy E; Csépány T; Kiss E; Rovensky J; Tuchynova A; Kozakova D; Doria A; Corocher N; Agmon-Levin N; Barak V; Orbach H; Zandman-Goddard G; Shoenfeld Y
    Ann Rheum Dis; 2010 Jun; 69(6):1155-7. PubMed ID: 20439290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
    Jesus D; Rodrigues M; Matos A; Henriques C; Pereira da Silva JA; Inês LS
    Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.